BCGitis or genitourinary tuberculosis? Diagnostic dilemma following intravesical Bacillus Calmette-Guérin therapy: a case report
Abstract
Introduction and importance: Intravesical Bacillus Calmette-Guérin (iBCG) therapy is a cornerstone in the management of non-muscle-invasive bladder cancer. Although generally safe, it can rarely lead to granulomatous inflammatory complications that closely mimic recurrent malignancy or genitourinary tuberculosis, particularly in tuberculosis-endemic regions.
Case report: A 47-year-old male with type 2 diabetes mellitus and high-grade T1 non-muscle-invasive bladder carcinoma underwent transurethral resection followed by iBCG induction and maintenance therapy. One month after completing the third maintenance cycle, he developed hematuria and persistent lower urinary tract symptoms. Urinalysis revealed sterile pyuria and hematuria, and imaging demonstrated a new focal bladder wall lesion. Cystoscopic biopsy showed granulomatous inflammation with caseous necrosis without malignancy. Urine was positive for acid-fast bacilli and Mycobacterium tuberculosis complex on GeneXpert. Considering the recent iBCG therapy, a diagnosis of BCG-associated granulomatous cystitis (BCGitis) was made. BCG therapy was stopped, and anti-tubercular therapy with isoniazid, rifampicin, and ethambutol was initiated.
Discussion: BCG-induced granulomatous cystitis represents a diagnostic challenge due to its clinical, radiological, and cystoscopic resemblance to bladder cancer recurrence and genitourinary tuberculosis. In tuberculosis-endemic settings, differentiating these entities is particularly…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.